News

Ignyta chairman, CEO, co-founder and MD Jonathan Lim said the collaboration with LUMC will enable Ignyta to study patients with undifferentiated arthritis and rheumatoid arthritis, taking the company

Under the agreement, Viropro will manufacture six monoclonal antibody products, being developed by Oncobiologics, including generic versions of Humira, Rituxan, Avastin, Herceptin, Erbitux and a non-disclosed biotherapeutic used

Fenofibrate Capsules, which are generic equivalent to Lupin Atlantis Holdings’ Antara Capsules, are indicated as an adjunct to diet to reduce elevated LDL-C, Total-C and Apo B, and

Pinoxacin Hydrochloride, a category 1.1 drug, is a DPP-4 inhibitor class of oral hypoglycemic agents used to enhance the function of endogenous insulin for improving glycemic control and

Kadcyla, which is designed by joining trastuzumab antibody with a chemotherapy drug DM1 using a stable linker, is indicated for use for the treatment of HER2-positive metastatic breast

As part of the deal, both the firms will evaluate anti-cancer drug conjugate by using Spirogen’s proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies generated

Ranbaxy recalled its atorvastatin from the US marketplace and stopped manufacturing the cholesterol lowering medicine in November, after it was found that the certain lots of 10 mg,

Under the deal, UCB and ConfometRx will leverage structural biology to gain insight into G-protein coupled receptor (GPCR) modulation towards the design of differentiated drugs. GPCRs, which are

The technology using iOS devices, including iPhone and iPad mobile digital devices aims to enable physicians and hospital staff to conversationally order patient medication and other medical function.